Guoping Wu

Title: Guoping Wu: Innovator in Immune Modulation

Introduction

Guoping Wu is a notable inventor based in Blaine, MN (US), recognized for his contributions to the field of immunotherapy. With a focus on compounds that modulate immune interactions, he has made significant strides in understanding and manipulating immune checkpoints.

Latest Patents

Guoping Wu holds 2 patents that highlight his innovative work. His latest patents include "Compounds that modulate the interaction of VISTA and VSIG3 and methods of making and using." This patent describes polyclonal and monoclonal antibodies that bind to VSIG3, as well as methods for modulating the interaction between VISTA and VSIG3. Another significant patent is "Identification of VSIG3/VISTA as a novel immune checkpoint and use thereof for immunotherapy." This patent identifies VSIG3 as the ligand for VISTA and explores its potential in developing agonist or antagonist compounds, particularly for cancer treatment and managing autoimmune conditions.

Career Highlights

Guoping Wu is currently associated with Bio-Techne Corporation, where he continues to advance his research in immune modulation. His work has implications for enhancing T cell immunity and developing therapies for various diseases.

Collaborations

He collaborates with esteemed colleagues, including Vassilios Kalabokis and Jinghua Wang, to further his research and innovation in the field.

Conclusion

Guoping Wu's contributions to immunotherapy through his patents and research at Bio-Techne Corporation underscore his role as a leading inventor in the field of immune modulation. His work has the potential to significantly impact cancer treatment and autoimmune disease management.